A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors: Two Year Outcomes.

Benjamin K Wilke Hillary W Garner Joseph M Bestic Lori A Chase Michael G Heckman Jennifer J Schoch Steven Attia

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)

Treatment of desmoid tumors with serial triamcinolone injections appears safe and well-tolerated by patients, with a 22% partial response based on RECIST. Further research is needed to confirm our results and determine factors predictive of response.

Keyphrases

ultrasound guided
type diabetes
metabolic syndrome
platelet rich plasma
weight loss
replacement therapy